In the US, Eliquis (apixaban systemic) is a member of the drug class factor Xa inhibitors and is used to treat Deep Vein Thrombosis, Deep Vein Thrombosis Prophylaxis after Hip Replacement Surgery, Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery, Deep Vein Thrombosis - Prophylaxis, Prevention of Thromboembolism in Atrial Fibrillation, Pulmonary Embolism, Thromboembolic Stroke Prophylaxis and Venous Thromboembolism.
Ingredient matches for Eliquis
Apixaban is reported as an ingredient of Eliquis in the following countries:
- Czech Republic
- New Zealand
- South Korea
- United Kingdom
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.